Hirudin Industry Research Report 2025
Description
Summary
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
According to APO Research, The global Hirudin market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Hirudin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Hirudin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hirudin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hirudin include etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.
The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Hirudin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Hirudin Segment by Company
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
Hirudin Segment by Type
Natural Hirudin
Recombinant Hirudin
Hirudin Segment by Application
Thrombosis Disease
Tumor Disease
Others
Hirudin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hirudin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hirudin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hirudin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
According to APO Research, The global Hirudin market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Hirudin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Hirudin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hirudin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hirudin include etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.
The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Hirudin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Hirudin Segment by Company
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
Hirudin Segment by Type
Natural Hirudin
Recombinant Hirudin
Hirudin Segment by Application
Thrombosis Disease
Tumor Disease
Others
Hirudin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hirudin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hirudin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hirudin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
136 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Hirudin by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.2.2 Natural Hirudin
- 2.2.3 Recombinant Hirudin
- 2.3 Hirudin by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Thrombosis Disease
- 2.3.3 Tumor Disease
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Hirudin Production Value Estimates and Forecasts (2020-2031)
- 2.4.2 Global Hirudin Production Capacity Estimates and Forecasts (2020-2031)
- 2.4.3 Global Hirudin Production Estimates and Forecasts (2020-2031)
- 2.4.4 Global Hirudin Market Average Price (2020-2031)
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hirudin Production by Manufacturers (2020-2025)
- 3.2 Global Hirudin Production Value by Manufacturers (2020-2025)
- 3.3 Global Hirudin Average Price by Manufacturers (2020-2025)
- 3.4 Global Hirudin Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Hirudin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Hirudin Manufacturers, Product Type & Application
- 3.7 Global Hirudin Manufacturers Established Date
- 3.8 Global Hirudin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 The Medicines Company
- 4.1.1 The Medicines Company Hirudin Company Information
- 4.1.2 The Medicines Company Hirudin Business Overview
- 4.1.3 The Medicines Company Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.1.4 The Medicines Company Product Portfolio
- 4.1.5 The Medicines Company Recent Developments
- 4.2 Keyken
- 4.2.1 Keyken Hirudin Company Information
- 4.2.2 Keyken Hirudin Business Overview
- 4.2.3 Keyken Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.2.4 Keyken Product Portfolio
- 4.2.5 Keyken Recent Developments
- 4.3 Minapharm
- 4.3.1 Minapharm Hirudin Company Information
- 4.3.2 Minapharm Hirudin Business Overview
- 4.3.3 Minapharm Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.3.4 Minapharm Product Portfolio
- 4.3.5 Minapharm Recent Developments
- 4.4 Abbott
- 4.4.1 Abbott Hirudin Company Information
- 4.4.2 Abbott Hirudin Business Overview
- 4.4.3 Abbott Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.4.4 Abbott Product Portfolio
- 4.4.5 Abbott Recent Developments
- 4.5 SALUBRIS
- 4.5.1 SALUBRIS Hirudin Company Information
- 4.5.2 SALUBRIS Hirudin Business Overview
- 4.5.3 SALUBRIS Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.5.4 SALUBRIS Product Portfolio
- 4.5.5 SALUBRIS Recent Developments
- 4.6 Pfizer, Inc
- 4.6.1 Pfizer, Inc Hirudin Company Information
- 4.6.2 Pfizer, Inc Hirudin Business Overview
- 4.6.3 Pfizer, Inc Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.6.4 Pfizer, Inc Product Portfolio
- 4.6.5 Pfizer, Inc Recent Developments
- 4.7 Teva Pharmaceutical Industries Ltd
- 4.7.1 Teva Pharmaceutical Industries Ltd Hirudin Company Information
- 4.7.2 Teva Pharmaceutical Industries Ltd Hirudin Business Overview
- 4.7.3 Teva Pharmaceutical Industries Ltd Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.7.4 Teva Pharmaceutical Industries Ltd Product Portfolio
- 4.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 4.8 DUOPUTAI
- 4.8.1 DUOPUTAI Hirudin Company Information
- 4.8.2 DUOPUTAI Hirudin Business Overview
- 4.8.3 DUOPUTAI Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.8.4 DUOPUTAI Product Portfolio
- 4.8.5 DUOPUTAI Recent Developments
- 4.9 Pentapharm
- 4.9.1 Pentapharm Hirudin Company Information
- 4.9.2 Pentapharm Hirudin Business Overview
- 4.9.3 Pentapharm Hirudin Production Capacity, Value and Gross Margin (2020-2025)
- 4.9.4 Pentapharm Product Portfolio
- 4.9.5 Pentapharm Recent Developments
- 5 Global Hirudin Production by Region
- 5.1 Global Hirudin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
- 5.2 Global Hirudin Production by Region: 2020-2031
- 5.2.1 Global Hirudin Production by Region: 2020-2025
- 5.2.2 Global Hirudin Production Forecast by Region (2026-2031)
- 5.3 Global Hirudin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
- 5.4 Global Hirudin Production Value by Region: 2020-2031
- 5.4.1 Global Hirudin Production Value by Region: 2020-2025
- 5.4.2 Global Hirudin Production Value Forecast by Region (2026-2031)
- 5.5 Global Hirudin Market Price Analysis by Region (2020-2025)
- 5.6 Global Hirudin Production and Value, YOY Growth
- 5.6.1 North America Hirudin Production Value Estimates and Forecasts (2020-2031)
- 5.6.2 Europe Hirudin Production Value Estimates and Forecasts (2020-2031)
- 5.6.3 China Hirudin Production Value Estimates and Forecasts (2020-2031)
- 5.6.4 Japan Hirudin Production Value Estimates and Forecasts (2020-2031)
- 6 Global Hirudin Consumption by Region
- 6.1 Global Hirudin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
- 6.2 Global Hirudin Consumption by Region (2020-2031)
- 6.2.1 Global Hirudin Consumption by Region: 2020-2025
- 6.2.2 Global Hirudin Forecasted Consumption by Region (2026-2031)
- 6.3 North America
- 6.3.1 North America Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Hirudin Consumption by Country (2020-2031)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Hirudin Consumption by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Hirudin Consumption by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East & Africa Hirudin Consumption by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
- 7 Segment by Type
- 7.1 Global Hirudin Production by Type (2020-2031)
- 7.1.1 Global Hirudin Production by Type (2020-2031) & (MT)
- 7.1.2 Global Hirudin Production Market Share by Type (2020-2031)
- 7.2 Global Hirudin Production Value by Type (2020-2031)
- 7.2.1 Global Hirudin Production Value by Type (2020-2031) & (US$ Million)
- 7.2.2 Global Hirudin Production Value Market Share by Type (2020-2031)
- 7.3 Global Hirudin Price by Type (2020-2031)
- 8 Segment by Application
- 8.1 Global Hirudin Production by Application (2020-2031)
- 8.1.1 Global Hirudin Production by Application (2020-2031) & (MT)
- 8.1.2 Global Hirudin Production Market Share by Application (2020-2031)
- 8.2 Global Hirudin Production Value by Application (2020-2031)
- 8.2.1 Global Hirudin Production Value by Application (2020-2031) & (US$ Million)
- 8.2.2 Global Hirudin Production Value Market Share by Application (2020-2031)
- 8.3 Global Hirudin Price by Application (2020-2031)
- 9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Hirudin Value Chain Analysis
- 9.1.1 Hirudin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Hirudin Production Mode & Process
- 9.2 Hirudin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hirudin Distributors
- 9.2.3 Hirudin Customers
- 10 Global Hirudin Analyzing Market Dynamics
- 10.1 Hirudin Industry Trends
- 10.2 Hirudin Industry Drivers
- 10.3 Hirudin Industry Opportunities and Challenges
- 10.4 Hirudin Industry Restraints
- 11 Report Conclusion
- 12 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
